BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19808192)

  • 1. Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer.
    Lennes IT; Lynch TJ
    Clin Lung Cancer; 2009 Sep; 10(5):341-6. PubMed ID: 19808192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.
    Hermens RP; Ouwens MM; Vonk-Okhuijsen SY; van der Wel Y; Tjan-Heijnen VC; van den Broek LD; Ho VK; Janssen-Heijnen ML; Groen HJ; Grol RP; Wollersheim HC
    Lung Cancer; 2006 Oct; 54(1):117-24. PubMed ID: 16920220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of integrated care for patients with nonsmall cell lung cancer: variations and determinants of care.
    Ouwens MM; Hermens RR; Termeer RA; Vonk-Okhuijsen SY; Tjan-Heijnen VC; Verhagen AF; Hulscher MM; Marres HA; Wollersheim HC; Grol RP
    Cancer; 2007 Oct; 110(8):1782-90. PubMed ID: 17724680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic standards and perspectives for stage IV non-small cell lung cancer].
    Reck M; Rosell R; Tiemann M
    Onkologie; 2012; 35 Suppl 3():10-3. PubMed ID: 22678019
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality assessment in oncology.
    Albert JM; Das P
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):773-81. PubMed ID: 22445001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice guidelines for non-small cell lung cancer.
    Cameron R; Fringer J; Taylor C; Gilden CR; Figlin RA
    Cancer J Sci Am; 1996; 2(3A Suppl):S61-8. PubMed ID: 9166525
    [No Abstract]   [Full Text] [Related]  

  • 7. Consensus conference: multimodality management of early- and intermediate-stage non-small cell lung cancer.
    Bordoni R
    Oncologist; 2008 Sep; 13(9):945-53. PubMed ID: 18779538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quality assurance].
    Flentje M; Hoffmann H; Huber RM
    Onkologie; 2012; 35 Suppl 3():14-6. PubMed ID: 22678020
    [No Abstract]   [Full Text] [Related]  

  • 9. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
    Grossi F; Tiseo M
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a lung cancer care coordination program on timeliness of care.
    Alsamarai S; Yao X; Cain HC; Chang BW; Chao HH; Connery DM; Deng Y; Garla VN; Hunnibell LS; Kim AW; Obando JA; Taylor C; Tellides G; Rose MG
    Clin Lung Cancer; 2013 Sep; 14(5):527-34. PubMed ID: 23827516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using nurse navigation to improve timeliness of lung cancer care at a veterans hospital.
    Hunnibell LS; Rose MG; Connery DM; Grens CE; Hampel JM; Rosa M; Vogel DC
    Clin J Oncol Nurs; 2012 Feb; 16(1):29-36. PubMed ID: 22297004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging of non-small cell lung cancer (NSCLC): a review.
    Tsim S; O'Dowd CA; Milroy R; Davidson S
    Respir Med; 2010 Dec; 104(12):1767-74. PubMed ID: 20833010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in the diagnosis and treatment of lung cancer.
    Gilligan D
    Int J Clin Pract; 1998; 52(5):330-4. PubMed ID: 9796565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgery and adjuvant therapy in non-small-cell lung carcinoma (NSCLC). (stage I through operable stage IIIA)].
    Eberhardt W; Fietkau R; Griesinger F; Passlick B; Stuschke M
    Onkologie; 2006 Sep; 29 Suppl 2():7-10. PubMed ID: 16974121
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
    J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer.
    Freeman RK; Van Woerkom JM; Vyverberg A; Ascioti AJ
    Eur J Cardiothorac Surg; 2010 Jul; 38(1):1-5. PubMed ID: 20206544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Goss G; Paszat L; Newman TE; Evans WK; Browman G
    Cancer Prev Control; 1998 Feb; 2(1):32-9. PubMed ID: 9765764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
    Wouters MW; Siesling S; Jansen-Landheer ML; Elferink MA; Belderbos J; Coebergh JW; Schramel FM
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adopting integrated care pathways in non-small-cell lung cancer: from theory to practice.
    Fasola G; Rizzato S; Merlo V; Aita M; Ceschia T; Giacomuzzi F; Lugatti E; Meduri S; Morelli A; Rocco M; Tozzi V
    J Thorac Oncol; 2012 Aug; 7(8):1283-90. PubMed ID: 22653077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.